NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
BXLS
ST13
US500000097097144Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
First use anywhere
First use in commerce
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Holders
Representatives
ERIC J. SHIMANOFF COWAN, LIEBOWITZ & LATMAN, P.C.
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
business consultation and advisory services; business consultation and advisory services related to life sciences; business consultation and advisory services related to health care; business consultation and advisory services related to clinical trials; business management consultation and advisory services; business management consultation and advisory services related to life sciences; business management consultation and advisory services related to health care; business management consultation and advisory services related to clinical trials; business planning consultation and advisory services; business planning consultation and advisory services related to life sciences; business planning consultation and advisory services related to health care; business planning consultation and advisory services related to clinical trials; business organizational consultation and advisory services; business organizational consultation and advisory services related to life sciences; business organizational consultation and advisory services related to health care; business organizational consultation and advisory services related to clinical trials; business operations consultation and advisory services; business operations consultation and advisory services related to life sciences; business operations consultation and advisory services related to health care; business operations consultation and advisory services related to clinical trials
Class 36
financial services, namely, asset management, advisory, research and analysis services; financial services, namely, asset management, advisory, research and analysis services related to life sciences; financial services, namely, asset management, advisory, research and analysis services related to health care; financial services, namely, asset management, advisory, research and analysis services related to clinical trials; financial services, namely, investment management, advisory, research and analysis services; financial services, namely, investment management, advisory, research and analysis services related to life sciences; financial services, namely, investment management, advisory, research and analysis services related to health care; financial services, namely, investment management, advisory, research and analysis services related to clinical trials; financial services, namely, commercial lending services; financial services, namely, commercial lending services in connection with life sciences; financial services, namely, commercial lending services in connection with health care; financial services, namely, commercial lending services in connection with clinical trials
Class 42
consulting services for others in the field of design, planning, management and implementation of clinical trials providing medical and scientific research information in the field of pharmaceuticals and clinical trials
History of USPTO decisions and trademark events.
9 publications found
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
REGISTERED-PRINCIPAL REGISTER
05/24/2022
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/22/2022
PUBLISHED FOR OPPOSITION
02/22/2022
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/02/2022
APPROVED FOR PUB - PRINCIPAL REGISTER
01/20/2022
ASSIGNED TO EXAMINER
01/18/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2021
NEW APPLICATION ENTERED
11/01/2021
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.